SEC Filings TLDR

On August 5, 2025, Steven Joseph Murray, a director of DraftKings Inc., engaged in several transactions involving Restricted Stock Units (RSUs). These transactions included the acquisition and disposition of RSUs, which represent a contingent right to receive shares of Class A Common Stock. Specifically, Murray acquire...

On August 5, 2025, DraftKings Inc. reported transactions involving Restricted Stock Units (RSUs) for director Harry Sloan. Sloan received 305 RSUs in lieu of a quarterly cash retainer, which were granted and fully vested on the same day. Additionally, he was granted 5,562 RSUs as part of an annual equity grant, which w...

On August 5, 2025, Marni M. Walden, a director of DraftKings Inc., was involved in several transactions related to Restricted Stock Units (RSUs). These transactions included the grant of 417 RSUs in lieu of a quarterly cash retainer, which became fully vested on the same day. Additionally, an annual equity grant of 5,5...

Dodge R Stanton, the Chief Legal Officer of DraftKings Inc., reported several transactions involving the company's Class A Common Stock on August 5, 2025. Stanton exercised stock options to acquire 66,382 shares at $3.29 per share and 38,718 shares at $2.95 per share. Additionally, Stanton sold 104,507 shares at a weig...

On August 5, 2025, Lindsay A. Rosenwald, MD, a director of Journey Medical Corp (ticker: DERM), reported ownership changes in the company's common stock. Rosenwald was granted 50,000 restricted stock units (RSUs) under the company's 2015 Stock Plan, as amended. These RSUs will vest in three equal installments on August...

On August 5, 2025, Justin Adam Smith, a director of Journey Medical Corp, was granted 20,000 restricted stock units (RSUs) under the company's 2015 Stock Plan, as amended. These RSUs will vest in three equal installments: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029, and 6,666 shares on August 5, 2030...

On August 5, 2025, Jayne Toledano Miranda, a director of Journey Medical Corp (ticker: DERM), was granted 20,000 restricted stock units (RSUs) under the company's 2015 Stock Plan, as amended. These RSUs will vest in three equal installments: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029, and 6,666 shar...

On August 5, 2025, Michael Cooper Pearce, a director of Journey Medical Corp, was granted 20,000 restricted stock units under the company's 2015 Stock Plan, as amended. These units will vest in three installments: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029, and 6,666 shares on August 5, 2030. Follow...

On August 5, 2025, Neil Herskowitz, a director of Journey Medical Corp, was granted 20,000 restricted stock units under the company's 2015 Stock Plan, as amended. These units will vest in three equal installments on August 5, 2028, August 5, 2029, and August 5, 2030. Following this transaction, Herskowitz owns a total ...

On August 5, 2025, Alexis Le-Quoc, Chief Technology Officer and Director of Datadog, Inc., engaged in multiple transactions involving the company's Class A and Class B Common Stock. Le-Quoc exercised stock options and converted Class B shares to Class A shares, resulting in the acquisition of 54,000 Class A shares and ...

On August 6, 2025, Michael R Conner, a director of Citizens Community Bancorp Inc., purchased 1,600 shares of the company's common stock at a weighted average price of $15.03 per share. The shares were acquired in multiple transactions with prices ranging from $15.01 to $15.05. Following this transaction, Conner owns a...

On August 5, 2025, Clint Stinchcomb, President and CEO of CuriosityStream Inc., reported the vesting of 600,000 restricted stock units (RSUs) out of a total of 2,400,000 RSUs granted on July 15, 2025. The vesting was triggered by the company achieving 35% year-over-year revenue growth for the first half of 2025. Additi...

Joel David Mayersohn, a director of Citius Oncology, Inc., reported ownership changes and stock options in the company. On July 28, 2025, Mayersohn acquired 21,228 shares of common stock through a distribution in kind from 10XYZ Holdings, the sponsor of TenX Keane Acquisition, the legacy entity of Citius Oncology. Addi...

William Guyer, Chief Development Officer of Corcept Therapeutics Inc., reported several transactions involving the company's common stock and stock options. On August 5, 2025, Guyer exercised stock options to acquire 14 shares of common stock at a price of $0.00 per share, with an exercise price of $21.65. Additionally...

Joseph P. Boyle, EVP Columbia Brand President of Columbia Sportswear Co, reported his stock ownership as of August 5, 2025. Boyle directly owns 2,732,271 shares of common stock. Additionally, he indirectly owns 209,603 shares through a trust and 19,270 shares through the JPB Irrevocable Trust. The transaction on August...

On August 5, 2025, Timothy P. Boyle, Chairman, President, and CEO of Columbia Sportswear Co., reported changes in his ownership of the company's common stock. Boyle transferred 38,540 shares, reducing his direct ownership to 11,271,220 shares. Additionally, he holds 11,659,819 shares through grantor retained annuity tr...

The SEC filing details the stock options transactions of Michael J. Cavanagh, President of Comcast Corp. The filing includes multiple transactions involving options to purchase Class A Common Stock, with varying exercise dates, expiration dates, and conversion prices. The options were granted on different dates (March ...

On August 5, 2025, Raymond Paul C, a director of Calumet, Inc., acquired Restricted Stock Units (RSUs) equivalent to shares of the company's common stock. The acquisition included 1,611 RSUs that are fully vested and will be settled upon the earlier of a specified date or the reporting person's termination date. Additi...

John G. Boss, a director of Calumet, Inc., acquired Restricted Stock Units (RSUs) on August 5, 2025. The RSUs are the economic equivalent of Calumet, Inc. common stock, with each RSU representing one share. Boss acquired 483 RSUs that are fully vested and will be settled upon the earlier of a specified date or his term...

On August 5, 2025, Stephen P. Mawer, a director of Calumet, Inc., acquired Restricted Stock Units (RSUs) equivalent to shares of the company's common stock. The RSUs are fully vested and will be settled upon the earlier of a specified date or Mawer's termination date. Mawer acquired 2,216 RSUs under one plan and 738 RS...

Amy M. Schumacher, a director of Calumet, Inc., acquired Restricted Stock Units (RSUs) on August 5, 2025. The RSUs are the economic equivalent of one share of Calumet, Inc. common stock. Schumacher acquired 1,474 RSUs that are fully vested and will be settled upon the earlier of the date specified by her or her termina...

On August 5, 2025, Charles Edward Bass, the Chief Alliance Officer of Climb Global Solutions, Inc. (CLMB), sold 362 shares of the company's common stock at a price of $107.32 per share. The shares were withheld at vesting of restricted stock to meet tax obligations. Following this transaction, Bass owns 26,661 shares o...

On August 5, 2025, Dale Foster, the Chief Executive Officer of Climb Global Solutions, Inc., disposed of 519 shares of common stock at a price of $107.32 per share. This transaction was related to the withholding of shares at the vesting of restricted stock to meet tax obligations. Following this transaction, Foster ow...

On August 5, 2025, Matthew Sullivan, the Chief Financial Officer of Climb Global Solutions, Inc., sold 227 shares of the company's common stock at a price of $107.32 per share. The shares were withheld at vesting of restricted stock to meet tax obligations. Following this transaction, Sullivan owns 19,588 shares of the...

On August 5, 2025, Timothy Popovich, the Chief Operating Officer of Climb Global Solutions, Inc., sold 260 shares of the company's common stock at a price of $107.32 per share. The shares were withheld at vesting of restricted stock to meet tax obligations. Following this transaction, Popovich owns 12,855 shares of the...